Met your annual insurance deductible?


Now may be the best time to upgrade to the MiniMed™ 780G system with an out-of-pocket cost as low as $0, compared to other times during the year.

Medtronic Champion Geoffrey

Compensated for his time. Thoughts and opinions are his own. Individual results may vary.

Post-meal hyperglycemia? Let your insulin pump system do the work for you.


The MiniMed™ 780G system helps prevent high glucose levels by taking action for you if your carb count is off!

It's the only system with Meal Detection™ technology that can detect if you've accidentally missed a dose or undercounted carbs, and automatically deliver corrections every 5 minutes to help prevent highs.

Medtronic Champion Jasmine

Compensated for her time. Thoughts and opinion are her own. Individual results may vary.

See how the automated insulin delivery system works


The MiniMed 780G system is designed with SmartGuard technology, an advanced algorithm that uses current and past sugar level trends to anticipate insulin needs, adjust insulin delivery, and automatically correct highs while helping to protect you from lows.


MiniMed 780G system features


Auto correction icon

Auto correction

If your carb counts aren’t exact or if you occasionally miss a meal dose, the system automatically delivers a correction dose.
Compatible with the Medtronic Extended™ infusion set icon

Compatibility with the Medtronic Extended™ infusion set

The first and only infusion set that can be worn for up to 7 days.
Personalized glucose targets icon

Personalized glucose targets

Flexible glucose targets as low as 100 mg/dL.§
No-fingersticks icon

No fingersticksΩ with SmartGuard technology

The Guardian 4 sensor sends sugar levels to the pump every 5 minutes with no fingersticks required when using SmartGuard technology.
MiniMed™ 780G system with SmartGuard™ technology

Ready to upgrade? Complete this form and a team member will reach out.

*Indicates fields that are required


How can we communicate with you?

I have read and understood the terms of this marketing authorization. I authorize Medtronic to use my protected health information for the purposes described in the authorization.

HIPAA MARKETING AUTHORIZATION FOR USE OF PROTECTED HEALTH INFORMATION

Medtronic Diabetes* respects the privacy of all our customers. With your permission, we may use your protected health information, including your contact information and health-related data, for marketing purposes, promotional offers, survey opportunities, and advertising that we think may be of interest to you. We may also share your information with Medtronic Diabetes representatives and contractors.  

Please note that this Authorization is optional, and you may refuse to opt in.  If you do not want to opt in, it will not affect your treatment, health insurance eligibility, or benefits, and you will not be stopped or prevented from accessing the CareLink™ Personal system, or other Medtronic Diabetes products, mobile apps, or services. You will be provided with a copy of this Authorization after it is acknowledged.

This Authorization will expire ten (10) years from the date you submit this authorization online but may expire sooner if required by applicable law, or if you remove it by following one of the methods below:

  1. E-mail takecontrol@medtronic.com
  2. Sign in to the Profile page and update your communication preferences at www.Diabetes.shop/communication
  3. Contact Customer Service Center at 800-646-4633

Opting out will not affect actions Medtronic Diabetes has already taken based on this Authorization. Information disclosed pursuant to this Authorization may be re-disclosed by the recipient of the information and may no longer be protected by federal privacy standards. If you have additional questions about this Authorization, please contact our Customer Service Center at 800-646-4633 or by email at takecontrol@medtronic.com.

Please review our Notice of Privacy Practices and Privacy Statement or contact our support team to get details on how Medtronic Diabetes processes your personal data, the involvement of affiliates and third-party data processors, cross-border transfer, and your rights as a data subject.

*MiniMed Distribution Corp. and Medtronic MiniMed, Inc. are “Medtronic Diabetes”

I agree to receive phone calls and/or artificial prerecorded marketing voice messages sent from or on behalf of Medtronic Diabetes using automated technology at the phone number(s) I have provided.

CONSENT FOR RECEIPT OF PHONE COMMUNICATIONS

You consent to receiving phone calls, including pre-recorded and auto-dialed communications, at the phone number(s) submitted above using automated technology from or on behalf of MiniMed Distribution Corp. and its business associate Medtronic MiniMed, Inc. (collectively “Medtronic Diabetes”), concerning the marketing, advertising and/or offers of sale of Medtronic Diabetes products, therapies and services. You also certify that you are (a) age 18 and older and (b) authorizing and consenting to use of the information provided for Medtronic Diabetes to contact you. Your consent is not a condition for purchase. Airtime, message and data rates may apply. You may opt out at any time by (i) e-mailing takecontrol@medtronic.com; or (ii) signing into your myHome profile and updating your communication preferences (www.diabetes.shop/communication).

I agree to receive marketing SMS text communications using automated technology sent from or on behalf of Medtronic Diabetes at the mobile phone number(s) I have provided (message frequency may vary).

CONSENT FOR RECEIPT OF TEXT COMMUNICATIONS

You consent to receiving text messages at the phone number(s) submitted above using automated technology from or on behalf of MiniMed Distribution Corp. and its business associate Medtronic MiniMed, Inc. (collectively “Medtronic Diabetes”), concerning the marketing, advertising and/or offers of sale of Medtronic Diabetes products, therapies and services. You also certify that you are (a) age 18 and older and (b) authorizing and consenting to use of the information provided for Medtronic Diabetes to contact you. Your consent is not a condition for purchase. Airtime, message and data rates may apply. You may opt out at any time by (i) texting "STOP" in return to a text; (ii) sending an email to takecontrol@medtronic.com; or (iii) signing into your myHome profile and updating your communication preferences (www.diabetes.shop/communication).



Support every step of the way

As your partner in care, we are here to help wherever you are on your diabetes journey.


Assistance
programs^

dollar sign icon
Living with diabetes comes with many barriers. Getting access to technology shouldn't be one of them. Learn more

Hands-on product
training

insulin pump icon
In-person or online trainings help you get started on the right foot and make sure you have everything you need to be successful on your new therapy.

24-Hour Technical
Support

handshaking icon
We offer around-the-clock support for any issues you might encounter. When you need us, call 1-800-646-4633 and select option 1.

Frequently asked questions


The MiniMed 780G system’s unique Meal Detection technology automatically corrects highs if carb counts are miscalculated or or an occasional bolus dose is missed. Only the MiniMed 780G insulin pump pairs with the new Guardian 4 sensor, which means no fingersticks with SmartGuard technology.Ω The system also has adjustable targets (100, 110, 120 mg/dL) so, with the help of your HCP, you can personalize your way to reach your diabetes goal.

Medtronic insulin pumps are covered by most insurance plans. Your out-of-pocket cost varies depending on your insurance. We also offer financial assistance and monthly payment programs. If you would like to receive an insurance coverage check at no cost, call 888-350-5440 (M-F 9:00 a.m. – 6:00 p.m. CT).

The Guardian 4 sensor does not require a blood glucose fingerstick to calibrate the system, or make treatment decisions with SmartGuard technology.Ω Fingersticks are required in manual mode, to enter SmartGuard, and when symptoms don't match.

When you use an insulin pump, you have a dramatic reduction in injections – by up to 96 percent.2 The infusion set that attaches to your body contains a small, flexible plastic cannula that is inserted to be placed under the skin and changed every 2-3 days, or up to 7 days with the Medtronic Extended infusion set. A CGM glucose sensor is inserted every 7 days.

The MiniMed 780G system is approved for people with type 1 diabetes age 7 and over. Learn more about options for insulin pump therapy for children.

If you would like a CGM and not an insulin pump, consider looking into the Guardian Connect CGM.
The MiniMed 780G system transmits to your smartphone via Bluetooth® technology. Check to see if your smartphone is compatible.

Footnotes
Taking a bolus 15 – 20 minutes before a meal helps to keep blood sugar levels under control after eating.
††  Refers to auto correct, which provides bolus assistance. Can deliver all auto correction doses automatically without user interaction, feature can be turned on and off.
Refers to SmartGuard™ feature. Individual results may vary.
§ Glucose targets should be chosen following a consultation with your healthcare provider.
Ω Fingersticks required in manual mode and to enter SmartGuard™. If symptoms don’t match alerts and readings, use a fingerstick. Refer to user guide. Pivotal trial participants spend avg of > 93% in SmartGuard™.
Not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
^ Terms and conditions apply.

References
1. Adults, T1 and parents of children with T1 diabetes < 18 years were surveyed.
2. Individual results may vary.
3. dQ&A US Diabetes Patient Panel Report; Customer Overall Satisfaction, n=146; Q4 2023: P.52 (November 2023).
4. Data on file. Medtronic. Northridge, CA. Survey data AHCL Positioning Concept Test, 2019.


Important safety information: MiniMed 780G system with SmartGuard technology with Guardian 4 sensor

The MiniMed 780G system is intended for continuous delivery of basal insulin at selectable rates, and the administration of insulin boluses at selectable amounts for the management of type 1 diabetes mellitus in persons seven years of age and older requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed 780G system includes SmartGuard technology, which can be programmed to automatically adjust insulin delivery based on the continuous glucose monitoring (CGM) sensor glucose values and can suspend delivery of insulin when the sensor glucose (SG) value falls below or is predicted to fall below predefined threshold values.

The Medtronic MiniMed 780G system consists of the following devices: MiniMed 780G insulin pump, the Guardian 4 transmitter, the Guardian 4 sensor, One-press serter, the Accu-Chek Guide Link blood glucose meter, and the Accu-Chek Guide test strips. The system requires a prescription from a healthcare professional.

The Guardian 4 sensor is intended for use with the MiniMed 780G system and the Guardian 4 transmitter to monitor glucose levels for the management of diabetes. The sensor is intended for single use and requires a prescription. The Guardian 4 sensor is indicated for up to seven days of continuous use.

The Guardian 4 sensor is not intended to be used directly to make therapy adjustments while the MiniMed 780G is operating in manual mode. All therapy adjustments in manual mode should be based on measurements obtained using a blood glucose meter and not on values provided by the Guardian 4 sensor. The Guardian 4 sensor has been studied and is approved for use in patients ages 7 years and older and in the arm insertion site only. Do not use the Guardian 4 sensor in the abdomen or other body sites including the buttocks, due to unknown or different performance that could result in hypoglycemia or hyperglycemia.

WARNING: Do not use the SmartGuard feature for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of at least 8 units, but no more than 250 units, is required to operate in the SmartGuard feature.

WARNING: Do not use the MiniMed 780G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed 780G system.

WARNING: Do not use SG values to make treatment decisions, including delivering a bolus, while the pump is in Manual Mode. When the SmartGuard feature is active and you are no longer in Manual Mode, the pump uses an SG value, when available, to calculate a bolus amount. However, if your symptoms do not match the SG value, use a BG meter to confirm the SG value. Failure to confirm glucose levels when your symptoms do not match the SG value can result in the infusion of too much or too little insulin, which may cause hypoglycemia or hyperglycemia.

Pump therapy is not recommended for people whose vision or hearing does not allow for the recognition of pump signals, alerts, or alarms. The safety of the MiniMed 780G system has not been studied in pregnant women, persons with type 2 diabetes, or in persons using other anti-hyperglycemic therapies that do not include insulin. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult https://www.medtronicdiabetes.com/important-safety-information#minimed-780g and the appropriate user guide at https://www.medtronicdiabetes.com/download-library